1398229-59-8Relevant articles and documents
DEOXYCYTIDINE KINASE INHIBITORS
-
Paragraph 0469, (2015/02/25)
Provided herein are compounds that bind to dCK and methods for treating cancer.
DEOXYCYTIDINE KINASE BINDING COMPOUNDS
-
, (2012/09/22)
The invention provides compounds that bind to deoxycytidine kinase (dCK) and compositions including pharmaceutically acceptable compositions containing the compounds. The compounds are useful in treating diseases and disorders where dCK activity is implicated such as cancer and immune disorders. The compounds also find use in clinical methodologies including positron emission tomography (PET) imaging.